News

Incyte (Nasdaq:INCY) today announced that data from numerous programs in its hematology/oncology portfolio will be presented at the 2025 European Hematology Association (EHA) congress, held June ...
Artificial camouflage has garnered long-standing interest in both academia and industry. The metasurface-based cloak has attracted much attention due to the powerful capability of manipulating the ...
–says Deputy CEO after meeting with political parties ahead of Nomination Day DEPUTY Chief Election Officer (CEO) Aneal Giddings has given the assurance that Guyana’s upcoming general and regional ...
Their results provide evidence that post-transplant cyclophosphamide (PTCy) effectively controls GVHD despite the use of peripheral blood stem cells, which will simplify stem cell transplants, ...
Two species of worms have retained remarkably similar patterns in the way they switch their genes on and off despite having split from a common ancestor 20 million years ago, a new study finds.
Niktimvo is a monoclonal antibody that blocks CSF1R. Corresponding author Kazumi Suzukawa, M.D., Ph.D., a medical director at Incyte, the maker of Niktimvo, and colleagues noted that a detailed study ...
Megan Fox and Machine Gun Kelly Did Not Name Their Baby ‘Vial of Blood’ That was the name I had my money on—but MGK revealed on Instagram that their daughter is named Saga Blade Fox-Baker.
Prime Are transparent toilets a practical solution or just another passing fad? Wednesday, June 18, 2025 ...
HOLYOKE — Holyoke Police Chief Brian Keenan announced that officers seized more than 100 vials of cocaine while conducting a quality-of-life property check on South Bridge Street on Tuesday at ...
BY SUZANNE PEREZKMUW/Kansas News Service WICHITA — Wichita school leaders say they are still investigating allegations of grade tampering at Southeast High School and will… ...
With these additions, all strengths of Zepbound vials will be available for $499 per month or less, with the 2.5 mg starter dose priced at $349.
INDIANAPOLIS, June 16, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in ...